Skip to main content
. 2020 Jul 19;12(7):2146. doi: 10.3390/nu12072146

Figure 2.

Figure 2

Effects of Thymocid® on the formation of advanced glycation end-products (AGEs) in two glycation models including bovine serum albumin (BSA)–fructose (A) and type I collagen cross-linking (B). The inhibitory effects of Thymocid® (50, 100, and 300 µg/mL) and aminoguanidine (AG) (a positive control) on the formation of AGEs and level of protein cross-linking were determined by fluorescent assays. Values are expressed in means ± standard deviation (S.D.) from three experiment replicates. Significance was defined as ** p < 0.01 and *** p < 0.001 when compared to the control group.